Our Previous Work
Every research endeavor we pursue shares one goal: improving life for people with type 1 diabetes.
In recent years, our research has led to valuable insights and real-world change. The impact and results of this work includes:
- Increasing insurance coverage for blood glucose test strips
- Improving standardized guidelines for pediatric A1c goals
- Advocating for Medicare coverage of CGM devices
- Identifying critical factors that impact A1c levels
- Evaluating the patient experience of using emergency glucagon
- Increasing CGM prescriptions and use
- Developing programs to help patients with A1c’s over 9%
- Increasing access to diabetes technology in certain racial/ethnic groups
- Improving mental health screen in both adult and pediatric clinics
- Increasing clinic visit frequency in Medicaid-insured youth
- Decreasing DKA hospitalizations through a targeted diabetes wellness program
- Increasing follow-up attendance after DKA hospitalizations
And much more!
Read more about our work here:
How industry partners are benefiting from collaborating with T1D Exchange
PROJECT: CGM company looking to compare outcomes for individuals with T1D using CGM vs traditional BGM
SCOPE: Investigate outcomes for both pump users and MDI
Identify hypoglycemic rates and DKA events
Categorize use of medical resources: clinic and ER visits, hospital admissions
Assess adherence and switching behavior between CGM & BGM
DURATION: Initial results 3 months; total engagement 12-18 months
PROJECT: Diabetes software company looking to better understand the patient reported experiences associated with mild/moderate fluctuations in blood glucose levels
SCOPE: Correlate patient-reported experience with CGM data profile
Explore how these fluctuations impact the patient’s health and well-being
DURATION: Total engagement 7 months